Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report-Reference-Cited by-同舟云学术

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report

Published:2018-07-30 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Merhi Maysaloun,Raza Afsheen,Inchakalody Varghese Philipose,Nashwan Abdulqadir Jeprel Japer,Allahverdi Niloofar,Krishnankutty Roopesh,Uddin Shahab,Zar Gul Abdul Rehman,Al Homsi Mohammed Ussama,Dermime Said

Funder

Hamad Medical Corporation

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Global epidemiology of oral and oropharyngeal cancer;Warnakulasuriya;Oral Oncol,2009

4. Modern treatment for nasopharyngeal carcinoma: current status and prospects;Rottey;Curr Opin Oncol,2011

5. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

2. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers;Biomedicine & Pharmacotherapy;2024-02

3. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR);European Journal of Pharmacology;2023-04

4. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy;Journal of Translational Medicine;2023-03-31

5. Expression and Prognostic Significance of PD-L1 and NY-ESO1 in Gallbladder Carcinoma;In Vivo;2023